<?xml version="1.0" encoding="UTF-8"?>



<records>

  <record>
    <language>eng</language>
          <publisher>Oriental Scientific Publishing Company</publisher>
        <journalTitle>Biomedical and Pharmacology Journal</journalTitle>
          <issn>0974-6242</issn>
            <publicationDate>2021-09-30</publicationDate>
    
        <volume>14</volume>
        <issue>3</issue>

 
    <startPage>1359</startPage>
    <endPage>1362</endPage>

	 
      <doi>10.13005/bpj/2237</doi>
        <publisherRecordId>40659</publisherRecordId>
    <documentType>article</documentType>
    <title language="eng">Reticulocyte Hemoglobin Content as a Best Indicator of Iron Deficiency in Female Patients with Diffuse Non-Scarring Hair Loss</title>

    <authors>
	 


      <author>
       <name>Zahraa Jasim</name>

 
		
	<affiliationId>1</affiliationId>
      </author>
    

	 


      <author>
       <name>Hayder Aledan</name>


		
	<affiliationId>2</affiliationId>

      </author>
    

	

	


	


	
    </authors>
    
	    <affiliationsList>
	    
		
		<affiliationName affiliationId="1">Department of Medicine, Division of Dermatology, College of Medicine, University of Basrah, Iraq</affiliationName>
    

		
		<affiliationName affiliationId="2">Department of Medicine, Division of Nephrology, College of Medicine, University of Basrah, Iraq</affiliationName>
    
		
		
		
		
	  </affiliationsList>






    <abstract language="eng">Background and objective: Iron deficiency is a well-documented cause of diffuse non-scarring hair loss. We aimed to find the best representative laboratory parameter for iron deficiency.

Methods:This was a cross-sectional observational study conducted on 51 female patients with diffuse non-scarring hair loss and iron deficiency state. Iron deficiency was diagnosed as serum ferritin below 30 ng/ml, TSAT below 20% or CHr below 29 pg.

Results: Among 51 female patients with diffuse non-scarring hair loss with laboratory proven iron deficiency; low CHrwas reported in 50 (98%) patients, low TSAT was reported in 43 (84.3%) patients, low serum ferritin was reported in 28 (55%).

Conclusion:The reticulocyte hemoglobin content (CHr) shows the highest frequency of iron deficiency in patients with diffuse hair loss and iron deficiency state.</abstract>

    <fullTextUrl format="html">https://biomedpharmajournal.org/vol14no3/reticulocyte-hemoglobin-content-as-a-best-indicator-of-iron-deficiency-in-female-patients-with-diffuse-non-scarring-hair-loss/</fullTextUrl>

<keywords language="eng">

      
        <keyword>Ferritin</keyword>
      

      
        <keyword> Hemoglobin</keyword>
      

      
        <keyword> Hair Loss</keyword>
      

      
        <keyword> Reticulocyte Hemoglobin Content</keyword>
      

      
        <keyword> Transferrin Saturation</keyword>
      
</keywords>
  </record>
</records>